Papers
1
Total Citations
13
H-Index
1
About
Dr. Shi Fu is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in robot-assisted radical cystectomy (RARC) for bladder cancer. His major contributions include leading an updated systematic review and meta-analysis (2024) comparing robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC) to open radical cystectomy (ORC), a study that has garnered 13 citations and clarified the differential effects on perioperative safety and effectiveness. This work is pivotal in resolving ongoing debates about the optimal surgical approach, highlighting iRARC’s potential to reduce complications while maintaining oncologic outcomes. Dr. Fu’s research has significantly influenced urologic oncology practice, with his meta-analysis serving as a key reference for surgeons worldwide. His notable achievements include advancing evidence-based guidelines for bladder cancer surgery and fostering the adoption of robotic techniques. With a growing citation impact, Dr. Fu continues to shape the future of urologic surgery, making him a vital resource for students and researchers exploring the intersection of technology and patient care.
Research Focus
Key Achievements
Top Papers
- 1